- Min.Order :0
- Purity: 98%
Keywords
Ubrogepant (3’S)-1’,2’,5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2’-oxo-spiro[6H-cyclopenta[b]pyridine-6,3’-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide
Quick Details
- Appearance:Powder
- Application:Ubrogepant is and selective oral calcitonin gene-related peptide (CGRP) receptor antagonist originated by Merck & Co. In Sep 2016, Allergan initiated a phase III extension trial for Migraine in USA.
- PackAge:inquiry
- ProductionCapacity:
- Storage:-20°C Freezer
- Transportation:inquiry
Superiority:
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
Details:
Migraine
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View